Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease

Pflugers Archiv European Journal of Physiology

Volumn 465, Issue 1, 2013, Pages 3-12

  Kobori, Hiroyuki ^a   Urushihara, Maki ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Angiotensinogen; Chronic kidney disease; Hypertension; Kidney; Renin angiotensin system

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; MESSENGER RNA; RENIN; RENIN INHIBITOR;

CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; DAHL SALT SENSITIVE RAT; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE COMPLEX; FEEDBACK SYSTEM; GENE EXPRESSION; GLOMERULONEPHRITIS; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE URINE LEVEL; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MICHAELIS MENTEN KINETICS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; URINALYSIS;

ANGIOTENSINOGEN; ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; RATS; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 84873061093     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-012-1143-6     Document Type: Review

References (129)

1. Anderson S, Jung FF, Ingelfinger JR (1993) Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486
2. Anonymous (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
3. Balam-Ortiz E, Esquivel-Villarreal A, Huerta-Hernandez D, Fernandez-Lopez JC, Alfaro-Ruiz L, Munoz-Monroy O, Gutierrez R, Figueroa-Genis E, Carrillo K, Elizalde A, Hidalgo A, Rodriguez M, Urushihara M, Kobori H, Jimenez-Sanchez G (2012) Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension. Hypertension 59:847-853
4. Baltatu O, Silva JA Jr, Ganten D, Bader M (2000) The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy. Hypertension 35:409-412
5. Bohlender J, Menard J, Ganten D, Luft FC (2000) Angiotensinogen concentrations and renin clearance: implications for blood pressure regulation. Hypertension 35:780-786
6. Brasier AR, Li J (1996) Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27:465-475
7. Brunner HR (1992) ACE inhibitors in renal disease. Kidney Int 42:463-479
8. Casarini DE, Boim MA, Stella RC, Krieger-Azzolini MH, Krieger JE, Schor N (1997) Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol 272:F405-F409
9. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038-2047
10. Danser AH, Admiraal PJ, Derkx FH, Schalekamp MA (1998) Angiotensin I-to-II conversion in the human renal vascular bed. J Hypertens 16:2051-2056
11. Darby IA, Congiu M, Fernley RT, Sernia C, Coghlan JP (1994) Cellular and ultrastructural location of angiotensinogen in rat and sheep kidney. Kidney Int 46:1557-1560
12. Darby IA, Sernia C (1995) In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res 281:197-206
13. Dell'Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S (1997) Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 100:253-258
14. Ding Y, Davisson RL, Hardy DO, Zhu LJ, Merrill DC, Catterall JF, Sigmund CD (1997) The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 272:28142-28148
15. Dzau VJ, Re R (1994) Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation 89:493-498
16. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K (1993) Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 268:11617-11621
17. Fukuda M, Urushihara M, Wakamatsu T, Oikawa T, Kobori H (2012) Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption. J Hypertens 30:1453-1459
18. Giatras I, Lau J, Levey AS (1997) Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 127:337-345
19. Gould AB, Green D (1971) Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5:86-89
20. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148
21. Hainault I, Nebout G, Turban S, Ardouin B, Ferre P, Quignard-Boulange A (2002) Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am J Physiol Endocrinol Metab 282:E59-E66
22. Harrison-Bernard LM, Zhuo J, Kobori H, Ohishi M, Navar LG (2002) Intrarenal AT1 receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 282:F19-F25
23. Hayakawa H, Coffee K, Raij L (1997) Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation 96:2407-2413
24. Hayashida W, Kihara Y, Yasaka A, Inagaki K, Iwanaga Y, Sasayama S (2001) Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. J Mol Cell Cardiol 33:733-744
25. Herrmann HC, Dzau VJ (1983) The feedback regulation of angiotensinogen production by components of the renin-angiotensin system. Circ Res 52:328-334
26. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348:2543-2556
27. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS (1999) Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol 276:F218-F227
28. Ingelfinger JR, Pratt RE, Ellison K, Dzau VJ (1986) Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest 78:1311-1315
29. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ (1990) In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85:417-423
30. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797
31. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, Yabana M, Watanabe Y, Sumida Y, Nagahara T, Ochiai H, Ishii M (1997) Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 30:1325-1330
32. Iwai J, Dahl LK, Knudsen KD (1973) Genetic influence on the renin-angiotensin system: low renin activities in hypertension-prone rats. Circ Res 32:678-684
33. Jang HR, Kim SM, Lee YJ, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG (2012) The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients. Ann Med 44:448-457
34. Jang HR, Lee YJ, Kim SR, Kim SG, Jang EH, Lee JE, Huh W, Kim YG (2012) Potential role of urinary angiotensinogen in predicting antiproteinuric effects of angiotensin receptor blocker in non-diabetic chronic kidney disease patients: a preliminary report. Postgrad Med J 88:210-216
35. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169-180
36. Joss N, Paterson KR, Deighan CJ, Simpson K, Boulton-Jones JM (2002) Diabetic nephropathy: how effective is treatment in clinical practice? QJM 95:41-49
37. Kamiyama M, Garner MK, Farragut KM, Kobori H (2012) The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys. Int J Mol Sci 13:5098-5111
38. Kamiyama M, Urushihara M, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, Kobori H (2010) Augmented intrarenal angiotensinogen mRNA expression parallels renal dysfunction in patients with type 2 diabetes. Hypertension 56:e135
39. Kang JJ, Toma I, Sipos A, Meer EJ, Vargas SL, Peti-Peterdi J (2008) The collecting duct is the major source of prorenin in diabetes. Hypertension 51:1597-1604
40. Katsurada A, Hagiwara Y, Miyashita K, Satou R, Miyata K, Ohashi N, Navar LG, Kobori H (2007) Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol 293:F956-F960
41. Kim SM, Jang HR, Lee YJ, Lee JE, Huh WS, Kim DJ, Oh HY, Kim YG (2011) Urinary angiotensinogen levels reflect the severity of renal histopathology in patients with chronic kidney disease. Clin Nephrol 76:117-123
42. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O (1995) Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 92:2735-2739
43. Kim YG, Song SB, Lee SH, Moon JY, Jeong KH, Lee TW, Ihm CG (2011) Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy. Clin Exp Nephrol 15:720-726
44. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Jacob H, Fuxe K, Ganten D, Kaling M (1992) High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 11:821-827
45. Kiyomoto H, Kobori H, Nishiyama A (2011) Chapter 4: renin-angiotensin system in the kidney and oxidative stress: local renin-angiotensin-aldosterone system and NADPH oxidase-dependent oxidative stress in the kidney. In: Miyata T, Eckardt KU, Nangaku M (eds) Studies on renal disorders. Oxidative stress in applied basic research and clinical practice. Springer Science + Business Media, LLC, Boston, pp 71-91
46. Klett C, Bader M, Ganten D, Hackenthal E (1994) Mechanism by which angiotensin II stabilizes messenger RNA for angiotensinogen. Hypertension 23:I120-I125
47. Kobori H, Alper AB, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG (2009) Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 53:344-350
48. Kobori H, Harrison-Bernard LM, Navar LG (2001) Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 37:1329-1335
49. Kobori H, Harrison-Bernard LM, Navar LG (2001) Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12:431-439
50. Kobori H, Harrison-Bernard LM, Navar LG (2002) Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61:579-585
51. Kobori H, Harrison-Bernard LM, Navar LG (2011) Chapter 8: role of activated renin-angiotensin system in pathogenesis of diabetic nephropathy. In: Prabhakar SS (ed) Advances in the pathogenesis of diabetic nephropathy. NovaScience Publishers, New York, pp 161-198
52. Kobori H, Katsurada A, Miyata K, Ohashi N, Satou R, Saito T, Hagiwara Y, Miyashita K, Navar LG (2008) Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol 294:F1257-F1263
53. Kobori H, Katsurada A, Ozawa Y, Satou R, Miyata K, Hase N, Suzaki Y, Shoji T (2007) Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun 358:156-163
54. Kobori H, Nangaku M, Navar LG, Nishiyama A (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59:251-287
55. Kobori H, Nishiyama A (2004) Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun 315:746-750
56. Kobori H, Nishiyama A, Abe Y, Navar LG (2003) Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41:592-597
57. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG (2003) Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 41:42-49
58. Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Yamamoto T (2008) Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens 2:349-354
59. Kobori H, Ozawa Y, Satou R, Katsurada A, Miyata K, Ohashi N, Hase N, Suzaki Y, Sigmund CD, Navar LG (2007) Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol 293:F938-F945
60. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A (2005) Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16:2073-2080
61. Kobori H, Ozawa Y, Suzaki Y, Prieto-Carrasquero MC, Nishiyama A, Shoji T, Cohen EP, Navar LG (2006) Young Scholars Award Lecture: intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens 19:541-550
62. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG (2004) AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43:1126-1132
63. Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG (2010) Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens 28:1422-1428
64. Kodama K, Adachi H, Sonoda J (1997) Beneficial effects of long-term enalapril treatment and low-salt intake on survival rate of Dahl salt-sensitive rats with established hypertension. J Pharmacol Exp Ther 283:625-629
65. Kohan DE (1998) Angiotensin II and endothelin in chronic glomerulonephritis. Kidney Int 54:646-647
66. Komlosi P, Fuson AL, Fintha A, Peti-Peterdi J, Rosivall L, Warnock DG, Bell PD (2003) Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 42:195-199
67. Konishi Y, Nishiyama A, Morikawa T, Kitabayashi C, Shibata M, Hamada M, Kishida M, Hitomi H, Kiyomoto H, Miyashita T, Mori N, Urushihara M, Kobori H, Imanishi M (2011) Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension 58:205-211
68. Kutlugun AA, Altun B, Aktan U, Turkmen E, Altindal M, Yildirim T, Yilmaz R, Arici M, Erdem Y, Turgan C (2012) The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients. Amyloid 19:28-32
69. Kutlugun AA, Altun B, Buyukasik Y, Aki T, Turkmen E, Altindal M, Yildirim T, Yilmaz R, Turgan C (2012) Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients? Transpl Int 25:13-18
70. Lafayette RA, Mayer G, Park SK, Meyer TW (1992) Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771
71. Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, Thomas J, Xiao S, Ishigami T, Herrmann T, Terreros DA, Ward K, Lalouel JM (2002) Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse. Hypertension 39:1007-1014
72. Lavoie JL, Lake-Bruse KD, Sigmund CD (2004) Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol 286:F965-F971
73. Lee YJ, Cho S, Kim SR, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG (2011) Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease. Postgrad Med J 87:664-669
74. Leehey DJ, Singh AK, Bast JP, Sethupathi P, Singh R (2008) Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats. Transl Res 151:208-216
75. Lu H, Boustany-Kari CM, Daugherty A, Cassis LA (2007) Angiotensin II increases adipose angiotensinogen expression. Am J Physiol Endocrinol Metab 292:E1280-E1287
76. Mao YN, Liu W, Li YG, Jia GC, Zhang Z, Guan YJ, Zhou XF, Liu YF (2012) Urinary angiotensinogen levels in relation to renal involvement of Henoch-Schonlein purpura in children. Nephrology (Carlton) 17:53-57
77. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I (2012) Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23:1181-1189
78. Mazzocchi G, Malendowicz LK, Markowska A, Albertin G, Nussdorfer GG (2000) Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats. Am J Physiol Endocrinol Metab 278:E1027-E1030
79. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr (2003) Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41:1346-1352
80. Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, Sigmund CD (1996) Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97:1047-1055
81. Mills KT, Kobori H, Hamm LL, Alper AB, Khan IE, Rahman M, Navar LG, Liu Y, Browne GM, Batuman V, He J, Chen J (2012) Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant 27:3176-3181
82. Miyata K, Ohashi N, Suzaki Y, Katsurada A, Kobori H (2008) Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol 35:922-927
83. Moe OW, Ujiie K, Star RA, Miller RT, Widell J, Alpern RJ, Henrich WL (1993) Renin expression in renal proximal tubule. J Clin Invest 91:774-779
84. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79
85. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y, Nishiyama A (2005) Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 16:703-711
86. Nakano D, Kobori H, Burford JL, Gevorgyan H, Seidel S, Hitomi H, Nishiyama A, Peti-Peterdi J (2012) Multiphoton Imaging of the Glomerular Permeability of Angiotensinogen. J Am Soc Nephrol. doi: 10.1681/ASN.2012010078
87. Nakaya H, Sasamura H, Mifune M, Shimizu-Hirota R, Kuroda M, Hayashi M, Saruta T (2002) Prepubertal treatment with angiotensin receptor blocker causes partial attenuation of hypertension and renal damage in adult Dahl salt-sensitive rats. Nephron 91:710-718
88. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H (2002) Regulation of intrarenal angiotensin II in hypertension. Hypertension 39:316-322
89. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA (2011) Intratubular renin-angiotensin system in hypertension. Hypertension 57:355-362
90. Navar LG, Satou R, Gonzalez-Villalobos RA (2012) The increasing complexity of the intratubular renin angiotensin system. J Am Soc Nephrol 23:1130-1132
91. Nishikimi T, Mori Y, Kobayashi N, Tadokoro K, Wang X, Akimoto K, Yoshihara F, Kangawa K, Matsuoka H (2002) Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension 39:1077-1082
92. Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M (2011) Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant 26:170-177
93. Nishiyama A, Nakagawa T, Kobori H, Nagai Y, Okada N, Konishi Y, Morikawa T, Okumura M, Meda I, Kiyomoto H, Hosomi N, Mori T, Ito S, Imanishi M (2008) Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. J Hypertens 26:1849-1859
94. Ogawa S, Kobori H, Ohashi N, Urushihara M, Nishiyama A, Mori T, Ishizuka T, Nako K, Ito S (2009) Angiotensin II type 1 receptor blockers reduce urinary angiotensinogen excretion and the levels of urinary markers of oxidative stress and inflammation in patients with type 2 diabetic nephropathy. Biomark Insights 4:97-102
95. Ohashi N, Urushihara M, Satou R, Kobori H (2010) Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species - ERK/JNK pathways. Hypertens Res 33:1174-1181
96. Otsuka F, Yamauchi T, Kataoka H, Mimura Y, Ogura T, Makino H (1998) Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in Dahl salt-sensitive rats. Am J Physiol 274:R1797-R1806
97. Park S, Bivona BJ, Kobori H, Seth DM, Chappell MC, Lazartigues E, Harrison-Bernard LM (2010) Major role for ACE-independent intrarenal ANGII formation in type II diabetes. Am J Physiol Renal Physiol 298:F37-F48
98. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285-2293
99. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, Bachmann S, Theilig F (2010) Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 285:41935-41946
100. Richoux JP, Cordonnier JL, Bouhnik J, Clauser E, Corvol P, Menard J, Grignon G (1983) Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res 233:439-451
101. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM (1999) Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 34:1265-1274
102. Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, Brezniceanu ML, Guo DF, Filep JG, Ingelfinger JR, Sigmund CD, Hamet P, Chan JS (2006) RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69:1016-1023
103. Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H (2009) Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 338:478-480
104. Sakata Y, Masuyama T, Yamamoto K, Doi R, Mano T, Kuzuya T, Miwa T, Takeda H, Hori M (2001) Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 37:293-299
105. Satou R, Gonzalez-Villalobos RA, Miyata K, Ohashi N, Katsurada A, Navar LG, Kobori H (2008) Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol 295:F283-F289
106. Satou R, Gonzalez-Villalobos RA, Miyata K, Ohashi N, Urushihara M, Acres OW, Navar LG, Kobori H (2009) IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol 311:24-31
107. Satou R, Miyata K, Gonzalez-Villalobos RA, Ingelfinger JR, Navar LG, Kobori H (2012) Interferon-gamma biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J 26:1821-1830
108. Satou R, Miyata K, Katsurada A, Navar LG, Kobori H (2010) Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells. Am J Physiol Cell Physiol 299:C750-C759
109. Sawaguchi M, Araki SI, Kobori H, Urushihara M, Haneda M, Koya D, Kashiwagi A, Uzu T, Maegawa H (2012) Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig 3:318-324
110. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ (1992) Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 263:E863-E869
111. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M (1996) Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension 28:403-408
112. Sigmund CD (2010) Structural biology: on stress and pressure. Nature 468:46-47
113. Singh R, Singh AK, Leehey DJ (2005) A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol 288:F1183-F1190
114. Smithies O (1997) Theodore Cooper Memorial Lecture. A mouse view of hypertension. Hypertension 30:1318-1324
115. Smithies O, Kim HS (1994) Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci U S A 91:3612-3615
116. Suzaki Y, Ozawa Y, Kobori H (2007) Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int J Biol Sci 3:40-46
117. Takamatsu M, Urushihara M, Kondo S, Shimizu M, Morioka T, Oite T, Kobori H, Kagami S (2008) Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol 23:1257-1267
118. Tamura K, Umemura S, Nyui N, Hibi K, Ishigami T, Kihara M, Toya Y, Ishii M (1998) Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch. Am J Physiol 275:R1-R9
119. Terada Y, Tomita K, Nonoguchi H, Marumo F (1993) PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 43:1251-1259
120. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T (2002) Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertension 40:834-839
121. Urushihara M, Kobori H (2011) Angiotensinogen expression is enhanced in the progression of glomerular disease. Int J Clin Med 2:378-387
122. Urushihara M, Kondo S, Kagami S, Kobori H (2010) Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am J Nephrol 31:318-325
123. Urushihara M, Ohashi N, Miyata K, Satou R, Acres OW, Kobori H (2011) Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension 57:586-593
124. Wehbi GJ, Zimpelmann J, Carey RM, Levine DZ, Burns KD (2001) Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors. Am J Physiol Renal Physiol 280:F254-F265
125. Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS (2008) Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 19:789-797
126. Ying WZ, Xia H, Sanders PW (2001) Nitric oxide synthase (NOS2) mutation in Dahl/Rapp rats decreases enzyme stability. Circ Res 89:317-322
127. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A (1999) Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33:108-115
128. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, Stein PE, Broughton Pipkin F, Read RJ (2010) A redox switch in angiotensinogen modulates angiotensin release. Nature 468:108-111
129. Zimpelmann J, Kumar D, Levine DZ, Wehbi G, Imig JD, Navar LG, Burns KD (2000) Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int 58:2320-2330